9 min listen
E36: Baricitinib for SLE
ratings:
Length:
14 minutes
Released:
Apr 4, 2019
Format:
Podcast episode
Description
This week I discuss the phase 2 trial on baricitinib in SLE. Though it's early times (and the total flop of rituxan in ME/CFS recently can attest to this), this was a large phase 2 and I'm hopeful it carries through to the ongoing phase 3 trials. Follow me on twitter and find all the papers / links at my new landing page, ebrheum.com!
Released:
Apr 4, 2019
Format:
Podcast episode
Titles in the series (87)
E6: Methylprednisolone and Cyclophosphamide, Alone or in Combinatinon, for Lupus Nephritis: Welcome back! Before we talk about cellcept for lupus nephritis, I decided we should flash back to 1996 and discuss one of the early trials that brought us cyclophosphamide. It's a quick discussion that will help set us up nicely for ALMS this Sunday. ... by The Evidence Based Rheumatology Podcast